Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,686,798
+$6,905,271 QoQ
Shares Held
2,044,007
+9.0% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 279 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. AUPH ranks #28 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in AUPH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,686,798 | 2,044,007 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $27,781,527 | 1,874,597 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $25,120,563 | 1,574,957 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $16,388,608 | 1,483,132 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $915,268 | 108,060 | Shares | Other | 2025-08-13 | |
| 2023-09-30 | $190,411 | 24,506 | Shares | Other | 2023-11-14 | |
| 2022-12-31 | $839,293 | 194,281 | Shares | Other | 2023-02-14 | |
| 2022-03-31 | $1,328,596 | 107,318 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $4,642,426 | 202,992 | Shares | Other | 2022-02-14 | |
| 2020-06-30 | $304,525 | 18,740 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||